Evidence for tissue factor expression in aortic valves in patients with aortic stenosis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 10, 2009, Pages 636-643

  Natorska, Joanna ^a   Marek, Grzegorz ^b   Hlawaty, Marta ^a   Sobczyk, Dorota ^b   Sadowski, Jerzy ^b   Tracz, Wiesława ^b   Undas, Anetta ^b  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aortic stenosis; Gradient; Tissue factor; Transvalvular

Indexed keywords

THROMBOPLASTIN;

ADULT; AORTA STENOSIS; AORTA VALVE; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MACROPHAGE; MALE; PROTEIN EXPRESSION; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 72249101968     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.791     Document Type: Article

References (30)

1. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol. 2006; 26: 1721-1728.
2. Otto CM, Kusist J, Reichenbach DD, et al. Characterization of the early lesion of "degenerative" valvular aortic stenosis: histological and immunohistochemical studies. Circulation. 1994; 90: 844-853.
3. Monty D, Pibarot P, Després JP, et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol. 2008; 28: 187-193.
4. Helske S, Lindstedt KA, Laine M, et al. Induction of local angiotensin II-producing system in stenotic aortic valves. J Am Coll Cardiol. 2004; 44: 1859-1866. (Pubitemid 39424087)
5. Kaden JJ, Dempfle CE, Grobholz R, et al. Interieukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis. 2003; 170: 205-211. (Pubitemid 37377791)
6. Wallby L, Janerot-Sjoberg B, Steffensen T, et al. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart. 2002; 88: 348-351.
7. Mohler ER III. Are atherosclerotic processes involved in aortic-valve calcification? Lancet. 2000; 356: 524-525.
8. Aronow WS, Ahn C, Kronzon I, et al. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001; 88: 693-695. (Pubitemid 32831111)
9. Ortlepp JR, Pilich M, Schmitz F, et al. Lower serum calcium levels are associated with grater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis. J Heart Valve Dis. 2006; 15: 502-508. (Pubitemid 44122679)
10. Pate GE. Association between aortic stenosis and hypertension. J Heart Valve Dis. 2002; 11: 612-614.
11. Singh R, Storni JA, Ondrovic L, et al. Age-related changes in the aortic valve affect leaflet stress distributions: implications for aortic valve degeneration. J Heart Valve Dis. 2008; 17: 290-298.
12. Dimitrow PP, Hlawaty M, Undas A, et al. Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden. Atherosclerosis. 2009; 204: 103-108.
13. Marechaux S, Corseaux D, Vincentelli A, et al. Identification of tissue factor in experimental aortic valve sclerosis. Cardiovasc Path. 2009; 18: 67-76.
14. Stein PD, Sabbah HN, Pitha JV. Continuing disease process of calcific aortic stenosis. Role of microthrombi and turbulent flow. Am J Cardiol. 1977; 39: 159-163.
15. Mazzolai L, Silacci P, Bouzourene K, et al. Tissue factor activity is up-regulated in human endothelial cells exposed to oscillatory shear stress. Thromb Haemost 2002; 87: 1062-1068. (Pubitemid 34624891)
16. Teirstein P, Yaager M, Yock PG, et al. Doppler echocardiographic measurement of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula. J Am Coll Cardiol. 1986; 8: 1059-1065. (Pubitemid 16009090)
17. Osman L, Chester AH, Sarathchandra P, et al. A novel role of the sympatho-adrenergenic system in regulating valve calcification. Circulation. 2007; 116: 282-287. (Pubitemid 47480802)
18. Lamprecht MR, Sabatini DM, Carpenter AE. CellProfiler: free, versalite software for auto mated biological image analysis. Biotechniques. 2007; 42: 71-75.
19. O'Brien KD, Reichenbach DD, Marcovina SM, et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesions of " degenerative" valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996; 16: 523-532.
20. Mothy D, Pibarot P, Despres JP, et al. Associations between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol. 2008; 28: 187-193.
21. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol. 1999; 19: 1218-1222. (Pubitemid 29227640)
22. Marutsuka K, Hatakeyama K, Sato Y, et al. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VII a complex. Thromb Res. 2002; 107: 271-276. (Pubitemid 35435387)
23. Riddle JM, Magillian DJ, Stein PD. Surface topography of stenotic aortic valves by scaning electron microscopy. Circulation. 1980; 61: 496-502.
24. Natorska J, Marek G, Hlawaty J, et al. Evidence for fibrin presence and tissue factor expression in aortic valves in patients with aortic stenosis: associations with transvalvular gradient. Eur Heart J. 2009; 30 (Suppl), P5559.
25. Mackman N, Sawdey MS, Keeton MR, et al. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol. 1993; 143: 76-84. (Pubitemid 24058162)
26. Rabkin E, Aikawa M, Stone JR, et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001; 104: 2525-2532. (Pubitemid 33104788)
27. Breyne J, Juthier F, Marechaux S, et al. Human aortic stenosis: potential role of tissue factor in disease development. Eur Heart J. 2009; 30 (Suppl): P5564.
28. Bahler RC, Desser DR, Finkelhor RS, et al. Factors leading to progression of valvular aortic stenosis. Am J Cardiol. 1999; 84: 1044-1048.
29. Touat Z, Lepage L, Ollivier V, et al. Dilation-dependent activation of platelets and prothrombin in human thoracic ascending aortic aneurysm. Arterioscler Thromb Vasc Biol. 2008; 28: 940-946. (Pubitemid 351544111)
30. Monetti M, Canavesi M, Camera M, et al. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice. Pharmacol Res. 2007; 55: 441-449. (Pubitemid 46560397)